香港股市 將在 2 小時 27 分鐘 開市

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
138.00+1.00 (+0.73%)
收市:04:00PM EDT
138.00 0.00 (0.00%)
收市後: 05:31PM EDT

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
https://www.masimo.com

版塊Healthcare
行業Medical Devices
全職員工3,800

高階主管

名稱頭銜支付行使價出生年份
Mr. Joseph E. KianiFounder, CEO & Chairman2.28M1965
Mr. Micah YoungExecutive VP & CFO613.23k1979
Mr. Bilal MuhsinChief Operating Officer638.12k1981
Mr. Thomas Samuel McClenahanExecutive VP, General Counsel & Corporate Secretary513.14k1973
Mr. Tao Leopold LevyExecutive Vice President of Business Development430.83k1974
Mr. Paul HataishiSenior VP & Chief Accounting Officer1975
Mr. Yongsam LeeExecutive VP & Chief Information Officer1.1M1.2M1965
Dr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science Officer139.56k1945
Mr. Eli KammermanVice President of Business Development & Investor Relations
Mr. Jon ColemanPresident of Worldwide Sales, Professional Services & Medical Affairs584.59k5.57M1964
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

公司管治

截至 2024年5月1日 止,Masimo Corporation 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:3;董事會:8;股東權利:3;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。